COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
- PMID: 33862335
- PMCID: PMC8043002
- DOI: 10.1016/j.esmoop.2021.100108
COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment in
-
Response to: COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?ESMO Open. 2021 Jun;6(3):100109. doi: 10.1016/j.esmoop.2021.100109. Epub 2021 Apr 10. ESMO Open. 2021. PMID: 33845361 Free PMC article. No abstract available.
Comment on
-
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era.ESMO Open. 2021 Apr;6(2):100055. doi: 10.1016/j.esmoop.2021.100055. Epub 2021 Feb 12. ESMO Open. 2021. PMID: 33582382 Free PMC article.
References
-
- Welch H.G., Prorok P.C., O'Malley A.J., Kramer B.S. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–1447. - PubMed
-
- Broom A., Kenny K., Page A. The paradoxical effects of COVID-19 on cancer care: current context and potential lasting impacts. Clin Cancer Res. 2020;26:5809–5813. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
